TORCH |
TORCH |
Référence | Technique | Dénomination | Description | Conditionnement | Marquage |
---|---|---|---|---|---|
EI 2410-9601-L G | ELISA | Toxoplasma gondii antibody determination in CSF | purified antigens of Toxoplasma gondii | 96 puits | |
EI 2531-9601-1 L G | ELISA | Herpes simplex virus (HSV-1/2 Pool) antibody determination in CSF | HSV-1 : strain "Mac Intyre" (ATCC VR-539) HSV-2 : strain "MS" (ATCC VR-540) |
96 puits | |
EI 2531-9601-L G | ELISA | Herpes simplex virus 1 (HSV-1) antibody determination in CSF | glycoprotein C1 | 96 puits | |
EI 2532-9601-L G | ELISA | Herpes simplex virus 2 (HSV-2) antibody determination in CSF | glycoprotein G2 | 96 puits | |
EI 2570-9601-L G | ELISA | Cytomégalovirus (CMV) antibody determination in CSF | purified native antigens, strain "AD169 | 96 puits | |
EI 2590-9601-L G | ELISA | Virus de la Rubéole antibody determination in CSF | purified native antigens, strain "HPV-77 | 96 puits | |
DN 2410-1601-4 G * DN 2410-6401-4 G * |
Dot Blot | TO.R.C.H. Profile" (Toxoplasma gondii, virus de la Rubéole, CMV, HSV-1, HSV-2 separately) | membrane strip with antigens (EUROLINE) | 16 bandelettes 64 bandelettes |
RUO |
DN 2410-1601-4 M * DN 2410-6401-4 M * |
Dot Blot | TO.R.C.H. Profile" (Toxoplasma gondii, ROP1, virus de la Rubéole, CMV, HSV-1, HSV-2 separately) | membrane strip with antigens (EUROLINE) | 16 bandelettes 64 bandelettes |
RUO |
EI 2410-0208-8 L G | ELISA | CSQ pair of controls anti-Toxoplasma gondii | 8 x 2 puits | ||
EI 2410-9601 A | ELISA | Toxoplasma gondii | purified antigens of Toxoplasma gondii | 96 puits | |
EI 2410-9601 G | ELISA | Toxoplasma gondii | purified antigens of Toxoplasma gondii | 96 puits | |
EI 2410-9601 M | ELISA | Toxoplasma gondii incl. IgG/RF absorbent | purified antigens of Toxoplasma gondii | 96 puits | |
EI 2410-9601 P | ELISA | Toxoplasma gondii Screen | purified antigens of Toxoplasma gondii | 96 puits | |
EI 2410-9601-1 G | ELISA | Toxoplasma gondii avidity determination | purified antigens of Toxoplasma gondii | 96 puits | |
EI 2531-0208-10 L G | ELISA | CSQ pair of controls anti-HSV-1 | 8 x 2 puits | ||
EI 2531-0208-8 L G | ELISA | CSQ pair of controls anti-HSV-1/2 Pool | 8 x 2 puits | ||
EI 2531-9601-1 A | ELISA | Herpes simplex virus (HSV-1/2 Pool) | HSV-1 : strain "Mac Intyre" (ATCC VR-539) HSV-2 : strain "MS" (ATCC VR-540) |
96 puits | |
EI 2531-9601-1 G | ELISA | Herpes simplex virus (HSV-1/2 Pool) | HSV-1 : strain "Mac Intyre" (ATCC VR-539) HSV-2 : strain "MS" (ATCC VR-540) |
96 puits | |
EI 2531-9601-1 M | ELISA | Herpes simplex virus (HSV-1/2 Pool) incl. IgG/RF absorbent | HSV-1 : strain "Mac Intyre" (ATCC VR-539) HSV-2 : strain "MS" (ATCC VR-540) |
96 puits | |
EI 2531-9601-2 G | ELISA | Herpes simplex virus 1 (HSV-1) | glycoprotein C1 | 96 puits | |
EI 2531-9601-2 M | ELISA | Herpes simplex virus 1 (HSV-1) incl. IgG/RF absorbent | glycoprotein C1 | 96 puits | |
EI 2532-0208-8 L G | ELISA | CSQ pair of controls anti-HSV-2 | 8 x 2 puits | ||
EI 2532-9601-2 G | ELISA | Herpes simplex virus 2 (HSV-2) | glycoprotein G2 | 96 puits | |
EI 2532-9601-2 M | ELISA | Herpes simplex virus 2 (HSV-2) incl. IgG/RF absorbent | glycoprotein G2 | 96 puits | |
EI 2570-0208-8 L G | ELISA | CSQ pair of controls anti-Cytomégalovirus | 8 x 2 puits | ||
EI 2570-9601 G | ELISA | Cytomégalovirus (CMV) | purified native antigens, strain "AD169 | 96 puits | |
EI 2570-9601 M | ELISA | Cytomégalovirus (CMV) incl. IgG/RF absorbent | purified native antigens, strain "AD169 | 96 puits | |
EI 2570-9601-1 G | ELISA | Cytomégalovirus (CMV) avidity determination | purified native antigens, strain "AD169 | 96 puits | |
EI 2590-0208-8 L G | ELISA | CSQ pair of controls anti-virus de la Rubéole | 8 x 2 puits | ||
EI 2590-9601 G | ELISA | Virus de la Rubéole | purified native antigens, strain "HPV-77 | 96 puits | |
EI 2590-9601 M | ELISA | Virus de la Rubéole incl. IgG/RF absorbent | purified native antigens, strain "HPV-77 | 96 puits | |
EI 2590-9601-1 G | ELISA | Virus de la Rubéole avidity determination | purified native antigens, strain "HPV-77 | 96 puits | |
EI 2590-9601-2 M | ELISA | Virus de la Rubéole glycoprotein incl. IgG/RF absorbent | native, purified glycoproteins, strain "HPV-77 | 96 puits | |
FK 2410-1005 FK 2410-1010 |
IFI | Toxoplasma gondii | protozoan smear | 10 x 05 10 x 10 |
RUO |
FI 2410-1005 A * FI 2410-1010 A * |
IFI | Toxoplasma gondii | protozoan smear | 10 x 05 10 x 10 |
RUO |
FI 2410-1005 G FI 2410-1010 G |
IFI | Toxoplasma gondii | protozoan smear | 10 x 05 10 x 10 |
RUO |
FI 2410-1005 M FI 2410-1010 M |
IFI | Toxoplasma gondii | protozoan smear | 10 x 05 10 x 10 |
RUO |
FI 2410-1005 X FI 2410-1010 X |
IFI | Toxoplasma gondii | protozoan smear | 10 x 05 10 x 10 |
RUO |
CI 2410-0101 G CI 2410-0102 G |
IFI | Anticorps anti-Toxoplasma gondii | contrôle positif | 0.1 ml 0.25 ml |
|
CI 2410-0101 H | IFI | High-avid Anticorps anti-Toxoplasma gondii | contrôle positif | 0.1 ml | |
CI 2410-0101 M CI 2410-0102 M |
IFI | Anticorps anti-Toxoplasma gondii | contrôle positif | 0.1 ml 0.25 ml |
|
CI 2410-0101 X | IFI | Low-avid Anticorps anti-Toxoplasma gondii | contrôle positif | 0.1 ml | |
CI 2410-0101 Z CI 2410-0102 Z |
IFI | Toxoplasma gondii | contrôle négatif | 0.1 ml 0.25 ml |
|
FI 2410-1005-3 G | IFI | TO.R.C.H. Profile" Toxoplasma gondii Virus de la Rubéole Cytomégalovirus HSV mixture (1+2) |
10 x 05 | ||
FI 2531-1005 G | IFI | Herpes simplex virus 1 (HSV-1) | infected cells | 10 x 05 | |
FI 2531-1005 M | IFI | Herpes simplex virus 1 (HSV-1) | infected cells | 10 x 05 | |
FK 2531-1003-1 FK 2531-1005-1 FK 2531-1010-1 FK 2531-2005-1 |
IFI | BIOCHIP Mosaic" HSV-1/HSV-2 | 10 x 03 10 x 05 10 x 10 20 x 05 |
||
FI 2531-1003-1 G FI 2531-1005-1 G FI 2531-1010-1 G FI 2531-2005-1 G |
IFI | BIOCHIP Mosaic" HSV-1/HSV-2 | 10 x 03 10 x 05 10 x 10 20 x 05 |
||
FI 2531-1003-1 M FI 2531-1005-1 M FI 2531-1010-1 M FI 2531-2005-1 M |
IFI | BIOCHIP Mosaic" HSV-1/HSV-2 | 10 x 03 10 x 05 10 x 10 20 x 05 |
||
CI 2531-0101 G | IFI | Anticorps anti-Herpes simplex virus 1 (HSV-1) | contrôle positif | 0.1 ml | |
CI 2531-0101 M | IFI | Anticorps anti-Herpes simplex virus 1 (HSV-1) | contrôle positif | 0.1 ml | |
CI 2531-0101 Z | IFI | HSV-1/HSV-2 | contrôle négatif | 0.1 ml | |
FI 2532-1005 G | IFI | Herpes simplex virus 2 (HSV-2) | infected cells | 10 x 05 | |
FI 2532-1005 M | IFI | Herpes simplex virus 2 (HSV-2) | infected cells | 10 x 05 | |
CI 2532-0101 G | IFI | Anticorps anti-Herpes simplex virus 2 (HSV-2) | contrôle positif | 0.1 ml | |
CI 2532-0101 M | IFI | Anticorps anti-Herpes simplex virus 2 (HSV-2) | contrôle positif | 0.1 ml | |
FK 2536-1003 FK 2536-1005 FK 2536-1010 FK 2536-2005 FK 2536-2010 |
IFI | Herpes virus humain 6 (HHV-6) | infected cells | 10 x 03 10 x 05 10 x 10 20 x 05 20 x 10 |
|
FI 2536-1003 G FI 2536-1005 G FI 2536-1010 G FI 2536-2005 G FI 2536-2010 G |
IFI | Herpes virus humain 6 (HHV-6) | infected cells | 10 x 03 10 x 05 10 x 10 20 x 05 20 x 10 |
|
FI 2536-1003 M FI 2536-1005 M FI 2536-1010 M FI 2536-2005 M FI 2536-2010 M |
IFI | Herpes virus humain 6 (HHV-6) | infected cells | 10 x 03 10 x 05 10 x 10 20 x 05 20 x 10 |
|
CI 2536-0101 G | IFI | Anticorps anti-herpes virus humain 6 (HHV-6) | contrôle positif | 0.1 ml | |
CI 2536-0101 M CI 2536-0102 M |
IFI | Anticorps anti-herpes virus humain 6 (HHV-6) | contrôle positif | 0.1 ml 0.25 ml |
|
CI 2536-0101 Z CI 2536-0102 Z |
IFI | Herpes virus humain 6 (HHV-6) | contrôle négatif | 0.1 ml 0.25 ml |
|
FI 2570-1003 A FI 2570-1005 A FI 2570-1010 A |
IFI | Cytomégalovirus (CMV) | infected cells | 10 x 03 10 x 05 10 x 10 |
|
FI 2570-1003 G FI 2570-1005 G FI 2570-1010 G |
IFI | Cytomégalovirus (CMV) | infected cells | 10 x 03 10 x 05 10 x 10 |
|
FI 2570-1003 M FI 2570-1005 M FI 2570-1010 M |
IFI | Cytomégalovirus (CMV) | infected cells | 10 x 03 10 x 05 10 x 10 |
|
FI 2570-1005 X | IFI | Cytomégalovirus (CMV) | infected cells | 10 x 05 | |
CI 2570-0101 A | IFI | Anticorps anti-Cytomégalovirus (CMV) | contrôle positif | 0.1 ml | |
CI 2570-0101 G | IFI | Anticorps anti-Cytomégalovirus (CMV) | contrôle positif | 0.1 ml | |
CI 2570-0101 H | IFI | Anticorps anti-Cytomégalovirus (CMV) de forte avidité | contrôle positif | 0.1 ml | |
CI 2570-0101 M | IFI | Anticorps anti-Cytomégalovirus (CMV) | contrôle positif | 0.1 ml | |
CI 2570-0101 X | IFI | Anticorps anti-Cytomégalovirus (CMV) de faible avidité | contrôle positif | 0.1 ml | |
CI 2570-0101 Z | IFI | Cytomégalovirus (CMV) | contrôle négatif | 0.1 ml | |
FI 2590-1005 G | IFI | Virus de la Rubéole | infected cells | 10 x 05 | |
FI 2590-1005 X | IFI | Virus de la Rubéole | infected cells | 10 x 05 | |
CI 2590-0101 G | IFI | Anticorps anti-virus de la Rubéole | contrôle positif | 0.1 ml | |
CI 2590-0101 H | IFI | High-avid Anticorps anti-virus de la Rubéole | contrôle positif | 0.1 ml | |
CI 2590-0101 X | IFI | Low-avid Anticorps anti-virus de la Rubéole | contrôle positif | 0.1 ml | |
CI 2590-0101 Z | IFI | Virus de la Rubéole | contrôle négatif | 0.1 ml | |
DY 2531-1601-1 G DY 2531-2401-1 G |
Western Blot | EUROLINE-WB Herpes simplex virus 1 (HSV-1) plus HSV-2 type-specific glycoprotein G2 | whole antigen, SDS extract of HSV-1 plus purified gG2 | 16 bandelettes 24 bandelettes |
|
DY 2531-1601-1 M DY 2531-2401-1 M |
Western Blot | EUROLINE-WB Herpes simplex virus 1 (HSV-1) plus HSV-2 type-specific glycoprotein G2 | whole antigen, SDS extract of HSV-1 plus purified gG2 | 16 bandelettes 24 bandelettes |
|
DY 2570-1601 G * DY 2570-2401 G * |
Western Blot | Cytomégalovirus (CMV) | whole antigen, SDS extract | 16 bandelettes 24 bandelettes |
RUO |
DY 2570-1601 M * DY 2570-2401 M * |
Western Blot | Cytomégalovirus (CMV) | whole antigen, SDS extract | 16 bandelettes 24 bandelettes |
RUO |
DY 2590-2401 G | Western Blot | Virus de la Rubéole | whole antigen | 24 bandelettes |
EUROIMMUN France • Espace Villa Parc • L'Erable • 1 avenue Marne et Gondoire • 77600 Bussy-Saint-Martin
Tél. : 01 64 61 66 66 • Fax : 01 64 61 62 20 • euroimmun[at]euroimmun.fr